Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of OROS Methylphenidate in Adults with ADHD
NCT00307684Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of methylphenidate-OROS in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical. Started Jan 2006; status: completed.
02
Drugs
methylphenidate-OROS
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00307684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307684.